Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

Dutasteride safely treats hair loss without harming sexual function.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Oral contraceptives are effective for treating hyperandrogenism, while ovarian electrocautery is better for women with infertility.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Dutasteride may reduce insulin sensitivity and increase body fat.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Pexidartinib often causes liver issues and fatigue, especially in women.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Combined oral contraceptives and antiandrogens are effective for treating PCOS symptoms in older women.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Baicalin may help reduce excessive male hormone levels in PCOS.